National Association of Testing Authorities, Australia
Scope of Accreditation
Austin Pathology
Site
Austin Hospital
Accreditation No.
2741
Site No.
2734
Date of Accreditation
20 Oct 1989
Contact
Ms Emma Mackay P: +61 (03) 94965991
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
Ambulatory Care Centre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
Anatomical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Cervical cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Cervical smear; Liquid based cytology specimens from cervix | Cytological examination; Review and reporting of cervical cytological material |
| Anatomical pathology - Cytopathology - Gynaecological (non-cervical) cytological investigation for abnormalities, precancerous or cancerous changes or conditions | Vaginal smears; Vaginal tissue; Vault smears; Vulval smears | Cytological examination; Review and reporting of gynaecological (non-cervical tissue) cytological samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Other body fluids; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of nipple discharge or smears from squamous mucosal sites for the detection of cancerous or precancerous changes | Nipple discharge | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsyFNA Attendance | Fine needle aspirates (FNA) | Cytological examination; Rapid onsite evaluation (ROSE); Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Formalin-fixed tissue; Fresh tissue | Review and reporting of biopsy material to identify or exclude morphological abnormalities; Review and reporting of material to identify neurological diseases; Structured reporting | |
| Anatomical pathology - Tissue pathology - Examination of biopsy material by electron microscopyReporting only | Gluteraldehyde tissue | Review and reporting of biopsy material to identify or exclude ultra-structural morphological abnormalities; Structured reporting |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical (immunofluorescence) investigation | Fresh tissue; Frozen tissue | Detection of antigenic targets - Various |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
| Detection of antigenic targets - Various | ||
| Anatomical pathology - Tissue pathology - Mortuary facilities | Body; Body parts | Assessment - Level 3 mortuary |
| Anatomical pathology - Tissue pathology - Non-coronial autopsy services | Body; Body parts | Autopsy service and reporting |
Chemistry
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Calculi | Ammonium; Ammonium hydrogen urate; Apatite; Bilirubin; Brushite; Calcium; Calcium oxalate dihydrate (weddelite); Calcium oxalate monohydrate; Calcium phosphate; Carbonate; Cholesterol; Cystine; Hydrated calcium oxalate (whewellite); Hydroxylapatite (hydroxyapatite); Magnesium; Magnesium ammonium phosphate - Struvite; Oxalate; Phosphate; Silicon; Sulfate; Triple phosphate - Struvite; Urate; Uric acid; Whitlockite; Xanthine |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Urine | Alcohol |
| Urine | Ethylglucuronide (ETG) | |
| 6-Acetylmorphine; Amphetamines; Benzodiazepines; Cannabis; Cocaine; Opiates | ||
| 6-Acetylmorphine; Ethanol | ||
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Serum | Carbamazepine; Cyclosporin; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Methotrexate; Paracetamol (acetaminophen); Phenytoin (dilantin); Salicylate; Tacrolimus; Valproate (valproic acid, epilim); Vancomycin |
| Chemical pathology - Detection and/or quantitation of tumour markers | Serum | CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Carcinoembryonic antigen (CEA); Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index; Thyroglobulin; α-Fetoprotein (AFP) |
| Human chorionic gonadotropin (hCG) | ||
| β2-Microglobulin (B2M) | ||
| Chemical pathology - Detection of faecal occult blood | Faeces | Blood |
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Plasma | Renin |
| Plasma; Urine | Aldosterone | |
| Serum | Adrenocorticotropic hormone (ACTH); Anti-Mullerian hormone (AMH); Parathyroid hormone (PTH) | |
| Adrenocorticotropic hormone (ACTH); C-peptide; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Growth hormone; Insulin; Luteinising hormone (LH); Oestradiol; Procalcitonin; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone | ||
| Insulin-like growth factor 1 (IGF-1, somatomedin C) | ||
| Serum; Urine | Cortisol | |
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Further investigation of cardiac function | Serum | N-Terminal-pro b-type natriuretic peptide (NT-proBNP) |
| Troponin I | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Serum | Apolipoprotein A1; Apolipoprotein B; HDL - Quantitation; Lipoprotein subclasses |
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Alkaline phosphatase (ALP) isoenzymes |
| Bile acids - Quantitative; Caeruloplasmin; Haptoglobins; α1-Antitrypsin | ||
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Xanthochromia |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Glucose; Lactate; Protein - Total |
| Other body fluids; Urine | pH | |
| Plasma | Ammonia; Glucose; Lactate | |
| Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Amylase; Angiotensin converting enzyme (ACE); Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Conjugated; Bilirubin - Total; C-reactive protein (CRP); Cholesterol - LDL; Cholesterol - Total; Creatine kinase; Lactate; Lactate dehydrogenase (LDH); Lipase; Triglycerides; γ-Glutamyltransferase | |
| Serum; Urine | Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Osmolality | ||
| Urine | Microalbumin | |
| Chemical pathology - Investigation for folate deficiency | Serum | Folate |
| Chemical pathology - Iron studies | Serum | Ferritin |
| Iron; Transferrin | ||
| Chemical pathology - Markers of bone metabolism | Serum | Procollagen type 1 N-terminal propeptide (P1NP); β-Crosslaps (CTX) |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma | Homocysteine; β-Hydroxybutyrate |
| Chemical pathology - Quantitation of vitamins | Serum | Cobalamin (vitamin B12) |
| 1,25-Dihydroxyvitamin D; Vitamin D | ||
| Chemical pathology - Tests for thyroid function | Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Serum | Selenium; Zinc |
| Serum; Urine | Copper | |
| Immunopathology - Quantitation of complement proteins | Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF); Serum | Oligoclonal bands |
| Faeces | Calprotectin; Elastase | |
| Plasma; Serum | Cryoprecipitins | |
| Detection and quantitation of free kappa and free lambda light chains | ||
| Serum | Monoclonal proteins | |
| α1-Antitrypsin phenotype | ||
| Serum; Urine | Detection and quantitation of free kappa and free lambda light chains | |
| Detection of Bence Jones proteins; Monoclonal proteins | ||
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M |
| Immunoglobulin subclasses | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Clinical Pharmacology and Therapeutics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Biogenic amines | Plasma | Adrenaline; Dopamine; Noradrenaline |
| Plasma; Urine | 3-Methoxytyramine; Metanephrine; Normetanephrine | |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Plasma; Serum | Clozapine; Mycophenolate |
| Perhexiline |
Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Creatinine; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | International normalised ratio (INR) |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
Genetics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Genital swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Blood | Factor V Leiden; Prothrombin variant |
| Blood; Bone marrow | Blood borne tumours | |
| Qualitative calculation of p190 positive BCR::ABL1 transcripts; Quantitative calculation of p210 positive BCR::ABL1 transcripts | ||
| Blood borne tumours | ||
| MYD88 mutation analysis | ||
| Blood borne tumours; IgH gene rearrangement | ||
| Quantitative calculation of p210 positive BCR::ABL1 transcripts; Rare autosomal recessive single gene disorders | ||
| Blood; Bone marrow; Formalin-fixed paraffin-embedded (FFPE) tissues | Blood borne tumours | |
| Blood borne tumours; T-cell gene rearrangement | ||
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genesReporting Only | Formalin-fixed paraffin-embedded (FFPE) tissues | Solid tumours |
| Molecular genetics - DNA extraction | Blood; Bone marrow; Formalin-fixed paraffin-embedded (FFPE) tissues | Viable DNA for sequencing |
| Molecular genetics - DNA sequencing | Extracted DNA | Sequenced DNA utilising massively parallel sequencing technologies |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood; Bone marrow | JAK2 mutation analysis |
| Myeloproliferative disorders | ||
| Formalin-fixed paraffin-embedded (FFPE) tissues | MLH1 promoter methylation analysis | |
| Solid tumours | ||
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood; Bone marrow | Blood borne tumours |
| Molecular genetics - RNA extraction | Tissues | Viable RNA for sequencing |
| Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes | Blood; Bone marrow | Blood borne tumours |
| Formalin-fixed paraffin-embedded (FFPE) tissues | Solid tumours | |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | VCF files | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Blood; Plasma | Snake venom detection |
| Haematology - Bone marrow examination | Bone marrow; Trephine | Examination of aspirated material |
| Haematology - Diagnosis of thalassemia | Blood | Haemoglobin A2 (HbA2) - Quantitation; Haemoglobin F (HbF) - Quantitation |
| Haematology - Examination of blood films by special staining | Blood | Malaria |
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Presence of foetal red blood cells |
| Feto-maternal haemorrhage (FMH) estimation | ||
| Haematology - Full blood examination | Blood | Differential number; Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Mean platelet volume (MPV); Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood; Plasma | Platelet aggregation |
| Heparin induced thrombotic thrombocytopenia (HITT) | ||
| Activated partial thromboplastin time (APTT); Anti-Xa - Apixaban; Anti-Xa - Rivaroxaban; Anti-Xa activity - Clexane - Low molecular weight heparin; Anti-thrombin III; Circulating coagulation factor inhibitors; Clauss fibrinogen; D-dimer; Danaparoid sodium; Derived fibrinogen; Factor II; Factor IX; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor X; Factor XI; Factor XII; Fibrinogen; International normalised ratio (INR); Lupus anticoagulant; Mixing studies - APTT; Polybrene; Protein C and protein S; Prothrombin time (PT); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Collagen binding activity | ||
| Heparin induced thrombocytopenia (HIT) - Confirmatory | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood | Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins |
| Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins | ||
| Haemoglobin fraction (S, C, D, E) - Quantitation; Other abnormal haemoglobins | ||
| Haematology - Investigation of haemolysis | Blood | Paroxysmal nocturnal haemoglobinuria (PNH) screen |
| Urine | Haemosiderin | |
| Haematology - Limited blood examination | Blood; Plasma | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow; Fluids; Fresh tissue | Assessment of lymphoid cell populations; Assessment of myeloid cell populations; CD10; CD103; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD16; CD19; CD1a; CD2; CD20; CD22; CD23; CD25; CD27; CD3; CD33; CD34; CD38; CD4; CD45; CD5; CD56; CD57; CD64; CD68; CD7; CD71; CD79a; CD8; CD9; FMC7; HLA-DR antigen; Immunoglobulin G1a (IgG1a); Kappa light chains; Lambda light chains; Myeloperoxidase; T-cell receptor aβ (TCRab); T-cell receptor γδ (TCRgd); Terminal deoxynucleotidyl transferase (TdT) |
| Immunopathology - Single HLA antigen typing | Blood | HLA-B27 |
| Immunopathology - Tests of cellular immunity - Lymphocyte function tests | Blood; Bone marrow; Other body fluids; Tissues | T-cell subsets; T-lymphocyte, B-lymphocyte and natural killer (TBNK) |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Blood; Plasma | Infectious mononucleosis |
Immunopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Further investigation of renal and/or hepatic function | Serum | Tryptase |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Serum | Anti-EJ antibodies; Anti-Jo-1 antibodies; Anti-Ku antibodies; Anti-Mi-2 antibodies; Anti-NXP2 antibodies; Anti-OJ antibodies; Anti-PL-12 antibodies; Anti-PL-7 antibodies; Anti-Pm/Scl-100 antibodies; Anti-Pm/Scl-75 antibodies; Anti-Ro-52 antibodies; Anti-SAE1 antibodies; Anti-melanoma differentiation associated gene 5 antibodies (MDA5); Anti-signal recognition particle antibodies (SRP); Anti-transcription intermediary factor antibodies (TIF1) |
| Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-neutrophil cytoplasmic antibodies - ANCA IIF; Anti-nuclear antibodies (ANA); Anti-smooth muscle antibodies (SMA) | ||
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-gastric parietal cell antibodies (GPC/PCA); Anti-intrinsic factor antibodies (IF) | ||
| Rheumatoid factor | ||
| Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO); Anti-thyroid stimulating hormone receptor antibodies (TSHRAb); Anti-thyrotropin receptor antibodies (TSHR) | ||
| Anti-cardiolipin antibodies (ACA); Anti-cyclic citrullinated peptide antibodies (CCP); Anti-gliadin antibodies (AGA); Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing [purified native and/or recombinant allergens]) | Serum | Casein - Milk; Galactose-α-1,3-galactose thyroglobulin - Bovine; Omega-5-gliadin - Wheat; α-Lactalbumin - Milk; β-Lactoglobulin - Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Cefaclor; Chlorhexidine; Gelatin - Bovine; Insulin - Human; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine; Suxamethonium (succinylcholine) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Cat dander; Cat epithelium; Chicken feathers; Dog dander; Dog epithelium; Duck feathers; Feather mix; Goose feathers; Guinea pig epithelium; Horse dander; Mouse epithelium; Mouse serum proteins; Mouse urine proteins; Pigeon feathers; Rabbit epithelium; Rat epithelium; Rat serum proteins; Rat urine proteins; Turkey feathers |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg; Egg white; Egg yolk; Turkey meat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Anchovy; Blue mussel; Codfish; Crab; Crayfish; Fish mix; Herring; Lobster; Mackerel; Octopus; Oyster; Plaice; Salmon; Sardine (pilchard); Scallop; Seafood mix; Shrimp; Squid; Trout; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Apricot; Aubergine (eggplant); Avocado; Banana; Blackberry; Blueberry; Carrot; Cherry; Fig; Fruit mix; Garlic; Grape; Grapefruit; Kiwi; Lemon citrus; Lettuce; Mandarin (tangerine, clementine, satsumas) citrus; Mango; Melon; Onion; Orange citrus; Passion fruit; Peach; Pear; Pineapple; Potato; Raspberry; Strawberry; Tomato; Watermelon |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Meat mix; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Cheese - Cheddar type; Cheese - Mould type; Goat milk; Milk; Sheep milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Cacao; Cocoa; Coffee; Honey; Mushroom; Staple food mix; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Cereal mix; Chick pea; Coconut; Corn; Gluten; Hazelnut; Lentil; Macadamia nut; Maize; Nut panel; Oat; Pea; Peanut; Pecan nut; Pinenut; Pistachio; Quinoa; Red kidney bean; Rice; Rye; Sesame seed; Soy bean; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [spices] allergens) | Serum | Anise; Basil; Caraway; Cardamon; Chilli pepper; Clove; Coriander (cilantro); Fennel seed; Ginger; Lovage; Mace; Marjoram; Mint; Paprika (sweet pepper); Spice mix; Tarragon; Thyme; Vanilla |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Bahia grass; Bermuda grass; Cultivated oat; Grass mix; Johnson grass; Meadow grass; Regional grass; Rye grass; Timothy grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | Cockroach; Fire ant; Mosquito |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Anisakis; Aspergillus fumigatus; Candida albicans; Cladosporium herbarum; Malassezia spp.; Penicillium chrysogenum (formerly Penicillium notatum); Staphylococcus enterotoxins; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Dermatophagoides farinae house dust mite; Dermatophagoides pteronyssinus house dust mite; House dust - Greer; House dust - Hollister-Stier; House dust mite mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | Formaldehyde/formalin; Latex; Oxirane (ethyleneoxide) |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Australian pine; Cypress; Elm; Eucalyptus; London plane; Maple leaf sycamore; Melaleuca; Olive; Pine; Recombinant birch; Recombinant birch profilin; Silver birch; Tree mix; White pine; Willow salix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Common wasp (yellow jacket) venom; European paper wasp venom; Honey bee venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Common ragweed; Goosefoot; Lamb’s quarters; Mugwort; Plantain - English; Russian thistle; Saltwort (prickly); Weed mix |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Other body fluids | Transferrin isoforms |
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Serum | Total immunoglobulin E |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Creatinine; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Mercy Hospital for Women Birthing Suite
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Mercy Hospital for Women Neonatal Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Microbiology
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Infusates; Isolates; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Plasma; Pus; Respiratory specimens; Sputum; Superficial sites; Synovial fluid; Throat swabs; Urine; Wound swabs | Bacteria; Pathogenic microorganisms |
| Aspirates; Blood; Cerebrospinal fluid (CSF); Ear swabs; Eye swabs; Fluids; General swabs; Genital swabs; Glass slide; Infusates; Isolates; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Operative specimens; Respiratory specimens; Skin; Sputum; Stem cells; Superficial sites; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Bacteria; Cultured pathogens identification; Pathogenic microorganisms | |
| Aspirates; Blood; Fluids | Bacteria; Pathogenic microorganisms | |
| Bacterial isolates | Pathogenic identification and antibiotic susceptibility | |
| Blood | Staphylococcus aureus | |
| Cerebrospinal fluid (CSF); Fluids | Bacteria; Pathogenic microorganisms | |
| Bacteria; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic microorganisms | ||
| Cerebrospinal fluid (CSF); Urine | Streptococcus pneumoniae antigen | |
| Genital swabs; Rectal swabs; Vaginal swabs | Streptococcus group B screening | |
| Human breast milk | Cultured pathogens identification; Quantification of pathogens in breast milk before and after pasteurisation | |
| Urine | Bacteria; Pathogenic microorganisms | |
| Bacteria; Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic microorganisms | ||
| Bilirubin; Glucose; Ketones; Leucocyte esterase; Nitrite; Proteins; Specific gravity; Urobilinogen; pH | ||
| Casts; Crystals; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC) | ||
| Microbiology - Bacteriology - Detection of pathogenic bacteria for epidemiological infection control surveillance | Bacterial isolates; Infection control swabs | Carbapenem resistant Enterobacteriaceae (CRE); Extended spectrum beta-lactamases (ESBL); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) |
| Carbapenem resistant Enterobacteriaceae (CRE); Extended spectrum beta-lactamases (ESBL); Methicillin resistant Staphylococcus aureus (MRSA); Vancomycin resistant Enterococci (VRE) | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air | Bacterial growth - Sterility |
| Air; Dialysis waters; Environmental swabs; Gastrointestinal endoscopes; Spore strips | Bacterial growth - Sterility | |
| Bacterial growth - Sterility | ||
| Environmental swabs | Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Metallo-β-lactamase (MBL) carbapenemase; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | |
| Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) | ||
| Infection control swabs | Yeast organism identification - Candida auris | |
| Yeast organism identification - Candida auris | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Aspirates; Bronchial washings; Bronchoalveolar lavage; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum | Bordetella bronchiseptica; Bordetella holmesii; Bordetella parapertussis; Bordetella pertussis; Chlamydophila pneumoniae; Chlamydophila psittaci; Legionella longbeachae; Legionella pneumophila; Mycoplasma pneumoniae |
| Bacterial isolates | Vancomycin resistant Enterococci (VRE) | |
| Blood | Staphylococcus aureus | |
| Faeces | Campylobacter coli; Campylobacter jejuni; Campylobacter spp.; Clostridioides difficile; Escherichia coli - Enteroinvasive (EIEC); Salmonella spp.; Shigella spp.; Shiga toxin | |
| Genital swabs; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Chlamydia trachomatis; Neisseria gonorrhoeae | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Bronchial washings; Nasopharyngeal aspirate; Respiratory swabs | Pneumocystis jirovecii |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Nasopharyngeal aspirate; Respiratory specimens; Sputum | Mycobacterium tuberculosis; Mycobacterium rifampicin resistance rpoB |
| Mycobacterium rifampicin resistance rpoB | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium hominis; Cryptosporidium parvum; Entamoeba histolytica; Giardia lamblia |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Aspirates; Bronchial washings; Bronchoalveolar lavage; Dry swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Adenovirus; Enterovirus; Human metapneumovirus; Influenza A virus; Influenza B virus; Parainfluenza virus type 1/2/3/4; Respiratory syncytial virus (RSV) A/B; Rhinovirus |
| Blood | Cytomegalovirus (CMV) | |
| Blood; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Nasopharyngeal swabs; Saliva; Throat swabs; Tissues; Urine | Cytomegalovirus (CMV) | |
| Cerebrospinal fluid (CSF) | Enterovirus; Epstein-Barr virus; Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Cerebrospinal fluid (CSF); Dry swabs; Eye swabs; Faeces; Fluids | Enterovirus | |
| Dry swabs; Eye swabs; Genital swabs | Herpes simplex virus (HSV); Varicella zoster virus (VZV) | |
| Faeces | Adenovirus; Astrovirus; Norovirus; Rotavirus; Sapovirus | |
| Liquid based cytology specimens | Human papilloma virus (HPV) | |
| Nasopharyngeal swabs; Saliva; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | ||
| Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Plasma | Hepatitis B virus (HBV) viral load; Hepatitis C virus (HCV) viral load | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Isolates | Purified PCR product |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma | Hepatitis C virus (HCV) viral load |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Cerebrospinal fluid (CSF); Isolates; Other body fluids; Respiratory specimens; Sputum; Tissues; Urine | Mycobacteria detection |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Cerebrospinal fluid (CSF); Serum | Cryptococcus antigen |
| General swabs; Hair; Nails; Skin; Skin scrapings; Tissues | Fungi identification; Fungi susceptibility; Yeast detection; Yeast susceptibility | |
| Isolates | Fungi identification; Fungi susceptibility; Yeast susceptibility; Yeasts identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Skin scrapings | Scabies | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Hepatitis C virus (HCV) |
| Cytomegalovirus (CMV); Epstein-Barr virus IgG antibody; Epstein-Barr virus IgM antibody; Epstein-Barr virus nuclear antigen; Epstein-Barr virus viral capsid antigen; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - IgG; Hepatitis B virus core antibody (anti-HBc) - IgM; Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Confirmatory; Hepatitis C virus (HCV); Hepatitis C virus antibody (anti-HCV) - IgG; Herpes simplex virus (HSV); Human immunodeficiency virus (HIV); Measles virus; Mumps virus; Mycoplasma spp.; Parvovirus; Rubella IgG antibody; Syphilis Treponema pallidum antibody; Toxoplasma; Varicella zoster virus (VZV) | ||
| Dengue virus |
Operating Theatre
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium; Carboxyhaemoglobin; Chloride; Deoxyhaemoglobin (HHb); Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Stem Cell Transplantation
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Immunopathology - Procedures related to the collection, processing, storage and issue of human haemopoietic progenitor cellsAllogeneic collection and/or processing; Autologous collection and/or processing; Products received from AN 17354 SN 19104; | Donor lymphocytes; Haemopoietic progenitor cells | Processing; Storage (includes freezing/thawing) |
Transfusion
ISO 15189 (2022)
Human Pathology
Medicare expiry date
16 Jul 2026
Last Activity Date
12 Mar 2024
| Service | Product | Determinant |
|---|---|---|
| Haematology - Investigation of haemolysis | Blood | Cold agglutinins |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood | Electronic crossmatch; Group checks of patient and donor; Immediate spin crossmatch; Indirect antiglobulin test (IAT) |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody titration |
| Antibody elution | ||
| Direct antiglobulin test (DAT, direct Coombs test); Other blood group antibodies; Red blood cell phenotyping; Rh | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products | Antibodies; Contamination - Microbiological |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood products | Issue and release of blood and blood products for transfusion |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
2741
Site No.
2734
Print date
21 Nov 2024
END OF SCOPE